Indian biotech firm Panacea Biotec on Wednesday said it is partnering with US-based Refana to make a potential vaccine for Covid-19. The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, it said. Panacea's shares jumped 20% on Wednesday after the news.